Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amneal Pharmaceuticals, Inc.
IPO Date: January 1, 1900
Sector: Healthcare
Industry: Biotech
Market Cap: $2.59B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 2.51%
Avg Daily Range (30 D): $0.11 | 1.37%
Avg Daily Range (90 D): $0.13 | 1.70%
Institutional Daily Volume
Avg Daily Volume: .38M
Avg Daily Volume (30 D): 1.19M
Avg Daily Volume (90 D): 1.42M
Trade Size
Avg Trade Size (Sh.): 152
Avg Trade Size (Sh.) (30 D): 95
Avg Trade Size (Sh.) (90 D): 96
Institutional Trades
Total Inst.Trades: 1,676
Avg Inst. Trade: $1.55M
Avg Inst. Trade (30 D): $2.34M
Avg Inst. Trade (90 D): $2.21M
Avg Inst. Trade Volume: .18M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.67M
Avg Closing Trade (30 D): $2.72M
Avg Closing Trade (90 D): $2.49M
Avg Closing Volume: 203.33K
   
News
Jul 18, 2025 @ 11:00 AM
Knight Therapeutics Announces Filing of New Drug S...
Source: Knight Therapeutics Inc.
Jul 18, 2025 @ 11:00 AM
Thérapeutique Knight annonce le dépôt dâ...
Source: Samira Sakhia
Jun 25, 2025 @ 12:00 PM
Amneal Highlights Positive Topline Results from Co...
Source: N/A
Jun 12, 2025 @ 12:00 PM
Amneal Receives U.S. FDA Approval for Prednisolone...
Source: Amneal Pharmaceuticals, Inc.
Jun 9, 2025 @ 8:56 AM
Selective Estrogen Receptor Modulators Market Rese...
Source: Researchandmarkets.Com
Financials
  TTM Q4 2024 FY 2024
Basic EPS $.04 $-.1 $-.38
Diluted EPS $.04 $-.1 $-.38
Revenue $ 695.42M $ 730.52M $ 2.79B
Gross Profit $ 255.89M $ 262.87M $ 1.02B
Net Income / Loss $ 24.62M $ -20.74M $ -73.88M
Operating Income / Loss $ 100.35M $ 75.79M $ 249.33M
Cost of Revenue $ 439.53M $ 467.65M $ 1.77B
Net Cash Flow $ -50.03M $ 40.08M $ 19.31M
PE Ratio 0.00    
Splits
Aug 26, 2013:   1:25